{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T10:26:34Z","timestamp":1648895194627},"reference-count":22,"publisher":"LLC Obyedinennaya Redaktsiya","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ter. arkh."],"published-print":{"date-parts":[[2015]]},"DOI":"10.17116\/terarkh201587858-66","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T11:30:07Z","timestamp":1461065407000},"page":"58","source":"Crossref","is-referenced-by-count":0,"title":["Use of a regional registry of chronic hepatitis patients to optimize antiviral therapy"],"prefix":"10.26442","volume":"87","author":[{"given":"L. I.","family":"Tkachenko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. V.","family":"Maleev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. V.","family":"Sannikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. V.","family":"Titorenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18344","reference":[{"key":"key-10.17116\/terarkh201587858-66-1","unstructured":"Yushchuk N.D., Znoiko O.O., Yakushechkina N.A., Dudina K.R., Shut'ko S.A., Kozina A.N., Safiullina N.Kh., Fedoseeva N.V., Belyi P.A., Lugovskikh E.A., Rakhmanova A.G., Khubutiya M.Sh., Pimenov N.N., Chulanov V.P., Chesnokov E.V., Ogarev V.V. Otsenka sotsial'no-ekonomicheskogo bremeni gepatita S v Rossiiskoi Federatsii. Epidemiologiya i vaktsinoprofilaktika. 2013;2(69):13-33."},{"key":"key-10.17116\/terarkh201587858-66-2","unstructured":"Pimenov N.N., Vdovin A.V., Komarova S.V. Mamonova N.A., Chulanov V.P., Pokrovskii V.I. Aktual'nost' i perspektivy vnedreniya v Rossii edinogo federal'nogo registra bol'nykh virusnymi gepatitami V i S. Terapevticheskii arkhiv. 2013;11:4-9."},{"key":"key-10.17116\/terarkh201587858-66-3","doi-asserted-by":"crossref","unstructured":"Christensen PB, Hay G, Jepsen P, Omland LH, Just SA, Krarup HB, Weis N, Obel N, Cowan S. Hepatitis C prevalence in Denmark \u2014 an estimate based on multiple national registers. BMC Infectious Diseases. 2012;12:178-185.","DOI":"10.1186\/1471-2334-12-178"},{"key":"key-10.17116\/terarkh201587858-66-4","doi-asserted-by":"crossref","unstructured":"Sweeting MJ, Hope VD, Hickman M, Parry JV, Ncube F, Ramsay ME, De Angelis D. Hepatitis C infection among injecting drug users in England and Wales (1992\u20142006): there and back again? Am J Epidemiol. 2009;170:352-360.","DOI":"10.1093\/aje\/kwp141"},{"key":"key-10.17116\/terarkh201587858-66-5","unstructured":"O sostoyanii sanitarno-epidemiologicheskogo blagopoluchiya naseleniya v Rossiiskoi Federatsii v 2013 godu: Gosudarstvennyi doklad. M.: Federal'naya sluzhba po nadzoru v sfere zashchity prav potrebitelei i blagopoluchiya cheloveka; 2014;191."},{"key":"key-10.17116\/terarkh201587858-66-6","unstructured":"Gosudarstvennyi doklad \u00abO sostoyanii sanitarno-epidemiologicheskogo blagopoluchiya naseleniya v Stavropol'skom krae v 2013 godu\u00bb. 2014;152."},{"key":"key-10.17116\/terarkh201587858-66-7","unstructured":"Glants S. Mediko-biologicheskaya statistika. Per s angl. M.: Praktika; 1998;459."},{"key":"key-10.17116\/terarkh201587858-66-8","doi-asserted-by":"crossref","unstructured":"Thompson AJ, Muir AJ, Sulkowski MS, Ge D, Fellay J, Shianna KV, Urban T, Afdhal NH, Jacobson IM, Esteban R, Poordad F, Lawitz EJ, McCone J, Shiffman ML, Galler GW, Lee WM, Reindollar R, King JW, Kwo PY, Ghalib RH, Freilich B, Nyberg LM, Zeuzem S, Poynard T, Vock DM, Pieper KS, Patel K, Tillmann HL, Noviello S, Koury K, Pedicone LD, Brass CA, Albrecht JK, Goldstein DB, McHutchison JG. Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus . Gastroenterology. 2010;139(1):120-129.","DOI":"10.1053\/j.gastro.2010.04.013"},{"key":"key-10.17116\/terarkh201587858-66-9","unstructured":"Khafisova O.O., Polikarpova T.S., Mazurchik N.V., Ogurtsov P.P. Vliyanie metformina na formirovanie ustoichivogo virusologicheskogo otveta pri provedenii kombinirovannoi protivovirusnoi terapii khronicheskogo gepatita S PegIFN\u03b1-2b i ribavirinom. Vestnik RUDN. 2011;2:47-55."},{"key":"key-10.17116\/terarkh201587858-66-10","unstructured":"Pis'mo ministra zdravookhraneniya RF \u211624\u20140\/10\/2\u20144915 ot 10 dekabrya 2012 goda."},{"key":"key-10.17116\/terarkh201587858-66-11","unstructured":"Yushchuk N.D., Safiullina N.Kh., Yur'eva A.E. Znoiko O.O., Dudina K.R., Lenkova D.O., Malyshev N.A., Myasnikov V.A., Belyi P.A., Kelli E.I. Analiz profilya bol'nykh virusnym gepatitom S, postupavshikh v infektsionnye statsionary g. Moskvy v 2010 godu. Lechashchii vrach. 2014;1:63-67."},{"key":"key-10.17116\/terarkh201587858-66-12","doi-asserted-by":"crossref","unstructured":"Mason AL, Lau JYN, Hoang N, Qian K, Alexander GJ, Xu L, Guo L, Jacob S, Regenstein FG, Zimmerman R, Everhart JE, Wasserfall C, Maclaren NK, Perrillo RP. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology. 1999;29:328-33.","DOI":"10.1002\/hep.510290235"},{"key":"key-10.17116\/terarkh201587858-66-13","doi-asserted-by":"crossref","unstructured":"Mehta SH, Brancati FL, Sulkowsky MS, Strathdee SA, Szklo M, Thomas DL. Prevalence type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med. 2000;133:592-599.","DOI":"10.7326\/0003-4819-133-8-200010170-00009"},{"key":"key-10.17116\/terarkh201587858-66-14","doi-asserted-by":"crossref","unstructured":"Knobler H, Schihmanter R, Zifroni A, Fenakel G, Schattner A. Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin Proc. 2000;75:355-359.","DOI":"10.4065\/75.4.355"},{"key":"key-10.17116\/terarkh201587858-66-15","doi-asserted-by":"crossref","unstructured":"Hadziyannis SJ, Sette H, Jr, Morgan TR, Balan V, Diago M, Marcellin P, Ramadori G, Bodenheimer H Jr, Bernstein D, Rizzetto M, Zeuzem S, Pockros PJ, Lin A, Ackrill AM; PEGASYS International Study Group. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. AnnIntern Med. 2004;140(5):346-355.","DOI":"10.7326\/0003-4819-140-5-200403020-00010"},{"key":"key-10.17116\/terarkh201587858-66-16","unstructured":"Van Vlierberghe H, Adler M, Bastens B, Colle I, Delwaide J, Henrion J, Horsmans Y, Michielsen P, Golstein P, Mulkay JP, Van Steenbergen W, Yap P, Nevens F, Denys AM, Brasseur JP. Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C: the PegIntrust Study. Acta Gastro-EnterologicaBelgica. 2010;LXXIII:5-11."},{"key":"key-10.17116\/terarkh201587858-66-17","unstructured":"Bondini S, Younossi ZM. Non-alcoholic fatty liver disease and hepatitis C infection. Minerva Gastroenterol Dietol. 2006;52(2):135-143."},{"key":"key-10.17116\/terarkh201587858-66-18","doi-asserted-by":"crossref","unstructured":"Poynard T, Ratziu V, McHutchison J, Manns M, Goodman Z, Zeuzem S, Younossi Z, Albrecht J. Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. Hepatology. 2003;38:75-85.","DOI":"10.1053\/jhep.2003.50267"},{"key":"key-10.17116\/terarkh201587858-66-19","doi-asserted-by":"crossref","unstructured":"Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP, Sobesky R, Martinot-Peignoux M, Maylin S, Nicolas-Chanoine MH, Paradis V, Vidaud M, Valla D, Bedossa P, Marcellin P. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology. 2008;134:416-423.","DOI":"10.1053\/j.gastro.2007.11.010"},{"key":"key-10.17116\/terarkh201587858-66-20","unstructured":"Antonova T.V., Romanova M.A., Sergeeva E.G. Khronicheskii gepatit S u bol'nykh s metabolicheskim sindromom. Zhurnal infektologii. 2011;3(3):91-96."},{"key":"key-10.17116\/terarkh201587858-66-21","unstructured":"Baizhanova Zh.Zh., Ignatova T.M., Severova M.M., Burnevich E.Z. Steatoz pecheni i insulinorezistentnost' pri khronicheskom gepatite S. Farmateka. 2012;7:26-29."},{"key":"key-10.17116\/terarkh201587858-66-22","unstructured":"Nikitin I.G., Bogomolov P.O. Insulinorezistentnost' i gepatit S: mogut li nashi predstavleniya izmenit' podkhody k lecheniyu? Farmateka. Gastroenterologiya, gepatologiya. 2007;2:15-19."}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T21:25:01Z","timestamp":1593379501000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/terapevticheskij-arkhiv\/2015\/8\/downloads\/ru\/380040-36602015087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015]]}},"alternative-id":["terarkh201587858-66"],"URL":"https:\/\/doi.org\/10.17116\/terarkh201587858-66","relation":{},"ISSN":["0040-3660"],"issn-type":[{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}